The association between protease inhibitors and anal cancer outcomes in veterans living with HIV treated with definitive chemoradiation: a retrospective study

The association between protease inhibitors and anal cancer outcomes in veterans living with HIV treated with definitive chemoradiation: a retrospective study

Abstract Background The incidence of anal squamous cell carcinoma has been increasing, particularly in people living with HIV (PLWH). There is concern that radiosensitizing drugs, such as protease inhibitors, commonly used in the management of HIV, may increase toxicities in patients undergoing chem...

Full description

Bibliographic Details
Main Authors: Alison K. Yoder, David S. Lakomy, Yongquan Dong, Suchismita Raychaudhury, Kathryn Royse, Christine Hartman, Peter Richardson, Donna L. White, Jennifer R. Kramer, Lilie L. Lin, Elizabeth Chiao
Format: Article
Language:English
Published: BMC 2021-07-01
Series:BMC Cancer
Subjects:
HIV
Protease inhibitors
Anal carcinoma
Squamous cell carcinoma
Chemoradiation
Online Access:https://doi.org/10.1186/s12885-021-08514-z

Internet

https://doi.org/10.1186/s12885-021-08514-z

Similar Items